Edwards Lifesciences Corp (EW) — Analysis Summary
Edwards Lifesciences Corp (EW) has a market cap of $49.79B with year-over-year revenue growth of +11.5%. Net margin stands at 17.7%. The stock trades at a P/E ratio of 45.4.
Key Takeaways
- Revenue changed +11.5% year-over-year
- Net margin of 17.7%
- P/E ratio of 45.4
Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, EW posted revenue growth of +11.5% and trades at a P/E of 45.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.